Exact Mass: 722.2715

Exact Mass Matches: 722.2715

Found 22 metabolites which its exact mass value is equals to given mass value 722.2715, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

jaspamide D

jaspamide D

C37H47BrN4O6 (722.2679)


A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.

   

Radiatoside F

Radiatoside F

C31H46O19 (722.2633)


   

gemmacolide AR

gemmacolide AR

C35H46O16 (722.2786)


   

gemmacolide AG

gemmacolide AG

C35H46O16 (722.2786)


   

6-O-alpha-L-(2-O-trans-cinnamoyl-3-O-isovaleryl)rhamnopyranosylcatalpol|gmelinoside M

6-O-alpha-L-(2-O-trans-cinnamoyl-3-O-isovaleryl)rhamnopyranosylcatalpol|gmelinoside M

C35H46O16 (722.2786)


   

javanicinoside H

javanicinoside H

C35H46O16 (722.2786)


   

( S )-(-)-DM-SEGPHOS

( S )-(-)-DM-SEGPHOS

C46H44O4P2 (722.2715)


   

(R)-(+)-5,5-Bis[di(3,5-xylyl)phosphino]-4,4-bi-1,3-benzodioxole,min.98(R)-DM-SEGPHOS

(R)-(+)-5,5-Bis[di(3,5-xylyl)phosphino]-4,4-bi-1,3-benzodioxole,min.98(R)-DM-SEGPHOS

C46H44O4P2 (722.2715)


   

Jasplakinolide D

Jasplakinolide D

C37H47BrN4O6 (722.2679)


A cyclodepsipeptide isolated from Jaspis splendens.

   

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C37H46N4O7S2 (722.2808)


   

1-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

1-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C37H46N4O7S2 (722.2808)


   

Naloxonazine (dihydrochloride)

Naloxonazine (dihydrochloride)

C38H44Cl2N4O6 (722.2638)


Naloxonazine dihydrochloride is a specific μ-opioid receptor antagonist with an IC50 of 5.4 nM. Naloxonazine dihydrochloride also shows anti-leishmanial activity[1][2][3].

   

(1s,2s,4s,7r,9r,11s,13r,14s,15r,16s,17r)-15-(acetyloxy)-4,14-dihydroxy-2,14,17-trimethyl-3-oxo-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-16-yl 2h-1,3-benzodioxole-5-carboxylate

(1s,2s,4s,7r,9r,11s,13r,14s,15r,16s,17r)-15-(acetyloxy)-4,14-dihydroxy-2,14,17-trimethyl-3-oxo-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-16-yl 2h-1,3-benzodioxole-5-carboxylate

C35H46O16 (722.2786)


   

2',12',14',16'-tetrakis(acetyloxy)-9'-[(acetyloxy)methyl]-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-15'-yl 3-methylbutanoate

2',12',14',16'-tetrakis(acetyloxy)-9'-[(acetyloxy)methyl]-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-15'-yl 3-methylbutanoate

C35H46O16 (722.2786)


   

4,22-dimethyl (1s,4s,5r,6s,7r,8r,10s,14s,16r,18s,19r,22s,23r,25s,26r)-23-(acetyloxy)-7,14-dihydroxy-4-methoxy-6-methyl-25-[(2-methylbutanoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4,22-dicarboxylate

4,22-dimethyl (1s,4s,5r,6s,7r,8r,10s,14s,16r,18s,19r,22s,23r,25s,26r)-23-(acetyloxy)-7,14-dihydroxy-4-methoxy-6-methyl-25-[(2-methylbutanoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4,22-dicarboxylate

C35H46O16 (722.2786)


   

(1s,4ar,5s,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl (1s,4as,7r,7ar)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

(1s,4ar,5s,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl (1s,4as,7r,7ar)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C31H46O19 (722.2633)


   

(1's,2r,2's,3's,4'r,7's,8'z,10'z,12's,13's,14'r,15'r,16'r)-2',12',14',16'-tetrakis(acetyloxy)-9'-[(acetyloxy)methyl]-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-15'-yl 3-methylbutanoate

(1's,2r,2's,3's,4'r,7's,8'z,10'z,12's,13's,14'r,15'r,16'r)-2',12',14',16'-tetrakis(acetyloxy)-9'-[(acetyloxy)methyl]-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-15'-yl 3-methylbutanoate

C35H46O16 (722.2786)


   

6,7-dihydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

6,7-dihydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C31H46O19 (722.2633)


   

(4r,7r,10r,13s,15e,17r,19s)-7-[(2-bromo-1h-indol-3-yl)methyl]-10-ethyl-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,13,15,17,19-pentamethyl-1-oxa-5,8,11-triazacyclononadeca-5,11,15-triene-2,9-dione

(4r,7r,10r,13s,15e,17r,19s)-7-[(2-bromo-1h-indol-3-yl)methyl]-10-ethyl-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,13,15,17,19-pentamethyl-1-oxa-5,8,11-triazacyclononadeca-5,11,15-triene-2,9-dione

C37H47BrN4O6 (722.2679)


   

(1's,2r,2's,3's,4'r,7's,8'z,10'e,12's,13's,14'r,15'r,16'r)-2',12',14',16'-tetrakis(acetyloxy)-9'-[(acetyloxy)methyl]-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-15'-yl 3-methylbutanoate

(1's,2r,2's,3's,4'r,7's,8'z,10'e,12's,13's,14'r,15'r,16'r)-2',12',14',16'-tetrakis(acetyloxy)-9'-[(acetyloxy)methyl]-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-15'-yl 3-methylbutanoate

C35H46O16 (722.2786)


   

15-(acetyloxy)-4,14-dihydroxy-2,14,17-trimethyl-3-oxo-11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-16-yl 2h-1,3-benzodioxole-5-carboxylate

15-(acetyloxy)-4,14-dihydroxy-2,14,17-trimethyl-3-oxo-11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-16-yl 2h-1,3-benzodioxole-5-carboxylate

C35H46O16 (722.2786)